StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1031
This month
13
This week
6
This year
106
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
8
Communications
8
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
18
Finance
5
Health care and social assistance
1
Health services
16
Health technology
1031
Industrial services
1
Information
4
Manufacturing
135
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
13
Producer manufacturing
16
Professional, scientific, and technical services
18
Retail trade
3
Technology services
16
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
8
Abbott laboratories
105
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
171
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
264
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
12
Novartis ag
1031
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
284
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Amex
6
Nasdaq
1031
Nyse
1031
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
6
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
23
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
48
19:00
43
20:00
35
20:20
3
21:00
26
22:00
43
23:00
40
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
www.biospace.com
86
www.globenewswire.com
173
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
764
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVSEF
save search
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published:
2024-03-25
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.86%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.94%
|
O:
-0.08%
H:
0.15%
C:
-0.44%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.75%
|
O:
0.06%
H:
0.96%
C:
0.26%
CAH
|
$108.19
2.07%
0.0%
1.5M
|
Distribution Services
|
-2.54%
|
O:
0.02%
H:
0.73%
C:
-0.02%
LNTH
|
$63.8
2.36%
2.3%
800K
|
Health Technology
|
8.12%
|
O:
0.1%
H:
1.98%
C:
-0.08%
reach
cancer
treatment
market
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.86%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.94%
|
O:
-0.08%
H:
0.15%
C:
-0.44%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-28.48%
|
O:
2.53%
H:
1.85%
C:
-2.31%
medical
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published:
2024-03-22
(Crawled : 12:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.79%
|
O:
0.17%
H:
0.28%
C:
-0.01%
fabhalta
first
chmp
positive
novartis
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published:
2024-03-22
(Crawled : 08:00)
- biospace.com/
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.79%
|
O:
0.17%
H:
0.28%
C:
-0.01%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
-0.28%
|
O:
0.94%
H:
0.11%
C:
-0.11%
acquisition
clearance
novartis
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.79%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-8.53%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.78%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published:
2024-03-20
(Crawled : 10:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.37%
|
O:
-1.37%
H:
0.0%
C:
-1.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.03%
|
O:
-0.62%
H:
0.45%
C:
0.34%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-7.77%
|
O:
-5.51%
H:
1.33%
C:
1.2%
management
commercial
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.84%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.52%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.71%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.49%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.96%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Pharmaceutical Continuous Manufacturing Market to grow by USD 548.94 million, 35% of market growth is expected in North America, Technavio
Published:
2024-03-14
(Crawled : 14:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.55%
|
O:
0.75%
H:
1.17%
C:
1.17%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-8.18%
|
O:
-0.39%
H:
0.7%
C:
-1.03%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.69%
|
O:
-0.6%
H:
0.07%
C:
-0.28%
HON
|
News
M
|
$194.27
1.67%
1.64%
3.6M
|
Producer Manufacturing
|
-2.74%
|
O:
-0.24%
H:
0.24%
C:
-1.46%
expected
growth
market
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-19.39%
|
O:
-0.66%
H:
4.19%
C:
3.13%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
-1.05%
|
O:
0.22%
H:
0.22%
C:
-0.93%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-11.76%
|
O:
0.03%
H:
1.47%
C:
-0.72%
year
update
financial
results
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.28%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.28%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.22%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Biologics Contract Development And Manufacturing Organization (CDMO) Market to grow by USD 10.63 billion, The availability of cost-efficient resources to boost market growth, Technavio
Published:
2024-03-12
(Crawled : 05:00)
- prnewswire.com
GIKLY
|
$4.58
132.75%
820
|
Manufacturing
|
-4.14%
|
O:
-4.79%
H:
0.0%
C:
-0.23%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.17%
|
O:
2.2%
H:
0.0%
C:
-2.57%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.92%
|
O:
-1.55%
H:
0.23%
C:
-0.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.32%
|
O:
1.04%
H:
0.0%
C:
0.0%
contract
market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.38%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.57%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.57%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.9%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.67%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.74%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.57%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.44%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-4.38%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.07%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-8.34%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.255
4.58%
4.38%
3M
|
Health Technology
|
30.77%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
$17.665
0.94%
0.93%
1.5M
|
Health Technology
|
-31.43%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.11
-8.67%
-9.49%
2.3M
|
Health Technology
|
-18.29%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
-17.59%
|
O:
1.11%
H:
0.96%
C:
0.65%
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published:
2024-03-06
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-6.81%
|
O:
0.64%
H:
1.7%
C:
0.54%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.58%
|
O:
0.2%
H:
0.71%
C:
0.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.63%
|
O:
-0.45%
H:
0.0%
C:
0.0%
ICLR
|
$288.32
-1.2%
-1.21%
640K
|
Health Technology
|
-14.09%
|
O:
2.54%
H:
0.22%
C:
-2.44%
trials
key
market
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published:
2024-03-05
(Crawled : 05:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-6.34%
|
O:
-0.09%
H:
0.86%
C:
0.6%
DGX
|
$128.44
2.01%
0.0%
1.6M
|
Health Services
|
2.5%
|
O:
0.38%
H:
0.69%
C:
-1.01%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.46%
|
O:
0.32%
H:
0.22%
C:
-0.2%
BIO
|
$279.73
-0.46%
0.0%
290K
|
Health Technology
|
-16.42%
|
O:
-0.53%
H:
1.08%
C:
-0.59%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-9.48%
|
O:
1.6%
H:
0.0%
C:
0.0%
QDEL
|
News
M
|
$39.09
2.17%
2.12%
1.1M
|
Health Technology
|
-11.75%
|
O:
0.18%
H:
1.13%
C:
-3.31%
report
respiratory
global
rsv
virus
diagnostics
growth
market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published:
2024-03-05
(Crawled : 01:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.46%
|
O:
0.32%
H:
0.22%
C:
-0.2%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.86%
|
O:
-0.24%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
1.17%
H:
0.0%
C:
0.0%
report
sciences
global
key
market
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
Published:
2024-03-04
(Crawled : 07:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.54%
|
O:
-0.6%
H:
0.68%
C:
0.51%
children
novartis
Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published:
2024-02-29
(Crawled : 20:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.76%
|
O:
-2.33%
H:
3.68%
C:
2.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-7.38%
|
O:
0.89%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.55%
|
O:
1.03%
H:
0.14%
C:
0.05%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.35%
|
O:
0.28%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.13%
|
O:
0.26%
H:
0.18%
C:
0.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.59%
|
O:
0.37%
H:
0.27%
C:
-0.1%
integration
reach
momentum
infection
treatment
market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.46
0.97%
0.96%
4.7M
|
Manufacturing
|
-11.36%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.52%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.56%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.91%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
51
52
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
UONE
|
$2.36
19.8%
16.53%
75K
|
Consumer Services
RWOD
|
$9.54
19.3%
16.18%
6.1M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.